As of Jun 27
| -5.47 / -5.31%|
The 8 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 160.00, with a high estimate of 208.00 and a low estimate of 61.00. The median estimate represents a +63.98% increase from the last price of 97.57.
The current consensus among 8 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.